299 related articles for article (PubMed ID: 25451009)
21. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins.
Newman RM; Salunkhe P; Godzik A; Reed JC
Infect Immun; 2006 Jan; 74(1):594-601. PubMed ID: 16369016
[TBL] [Abstract][Full Text] [Related]
22. Microbial Toll/interleukin 1 receptor proteins: a new class of virulence factors.
Cirl C; Miethke T
Int J Med Microbiol; 2010 Aug; 300(6):396-401. PubMed ID: 20451449
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a TIR-like protein from Paracoccus denitrificans.
Low LY; Mukasa T; Reed JC; Pascual J
Biochem Biophys Res Commun; 2007 May; 356(2):481-6. PubMed ID: 17362878
[TBL] [Abstract][Full Text] [Related]
24. Recombinant production of functional full-length and truncated human TRAM/TICAM-2 adaptor protein involved in Toll-like receptor and interferon signaling.
Ullah MO; Valkov E; Ve T; Williams S; Mas C; Mansell A; Kobe B
Protein Expr Purif; 2015 Feb; 106():31-40. PubMed ID: 25306876
[TBL] [Abstract][Full Text] [Related]
25. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
26. Molecular interactions in interleukin and toll-like receptor signaling pathways.
Snyder GA; Sundberg EJ
Curr Pharm Des; 2014; 20(8):1244-58. PubMed ID: 23713776
[TBL] [Abstract][Full Text] [Related]
27. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of bacterial TIR domains via immune signalling molecules.
Ofir G; Herbst E; Baroz M; Cohen D; Millman A; Doron S; Tal N; Malheiro DBA; Malitsky S; Amitai G; Sorek R
Nature; 2021 Dec; 600(7887):116-120. PubMed ID: 34853457
[TBL] [Abstract][Full Text] [Related]
29. Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains.
Mikami T; Miyashita H; Takatsuka S; Kuroki Y; Matsushima N
Gene; 2012 Jul; 503(2):235-43. PubMed ID: 22587897
[TBL] [Abstract][Full Text] [Related]
30. Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions.
Toshchakov VY; Vogel SN
Expert Opin Biol Ther; 2007 Jul; 7(7):1035-50. PubMed ID: 17665992
[TBL] [Abstract][Full Text] [Related]
31. The genome of the sponge Amphimedon queenslandica provides new perspectives into the origin of Toll-like and interleukin 1 receptor pathways.
Gauthier ME; Du Pasquier L; Degnan BM
Evol Dev; 2010; 12(5):519-33. PubMed ID: 20883219
[TBL] [Abstract][Full Text] [Related]
32. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
33. Bacterial TIR-containing proteins and host innate immune system evasion.
Rana RR; Zhang M; Spear AM; Atkins HS; Byrne B
Med Microbiol Immunol; 2013 Feb; 202(1):1-10. PubMed ID: 22772799
[TBL] [Abstract][Full Text] [Related]
34. Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling.
Enokizono Y; Kumeta H; Funami K; Horiuchi M; Sarmiento J; Yamashita K; Standley DM; Matsumoto M; Seya T; Inagaki F
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19908-13. PubMed ID: 24255114
[TBL] [Abstract][Full Text] [Related]
35. A survey of TIR domain sequence and structure divergence.
Toshchakov VY; Neuwald AF
Immunogenetics; 2020 Apr; 72(3):181-203. PubMed ID: 32002590
[TBL] [Abstract][Full Text] [Related]
36. A novel Toll like receptor with two TIR domains (HcToll-2) is involved in regulation of antimicrobial peptide gene expression of Hyriopsis cumingii.
Ren Q; Lan JF; Zhong X; Song XJ; Ma F; Hui KM; Wang W; Yu XQ; Wang JX
Dev Comp Immunol; 2014 Jul; 45(1):198-208. PubMed ID: 24631579
[TBL] [Abstract][Full Text] [Related]
37. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
38. The role of protein-protein interactions in Toll-like receptor function.
Berglund NA; Kargas V; Ortiz-Suarez ML; Bond PJ
Prog Biophys Mol Biol; 2015 Oct; 119(1):72-83. PubMed ID: 26144017
[TBL] [Abstract][Full Text] [Related]
39. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.
Couillault C; Pujol N; Reboul J; Sabatier L; Guichou JF; Kohara Y; Ewbank JJ
Nat Immunol; 2004 May; 5(5):488-94. PubMed ID: 15048112
[TBL] [Abstract][Full Text] [Related]
40. Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.
Matsumoto M; Funami K; Oshiumi H; Seya T
Prog Mol Biol Transl Sci; 2013; 117():487-510. PubMed ID: 23663980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
